In this article, we provide updated data on ruxolitinib therapy for patients with myelofibrosis and offer expert opinion on the appropriate use of this agent in the community practice.
Ehab L. Atallah, MD
Advertisement
Articles by Ehab L. Atallah, MD
Advertisement
Latest Updated Articles
Clarifying the Use of Ruxolitinib in Patients With MyelofibrosisPublished: July 15th 2013 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
ESMO 2025: Key Anticipated Updates in Breast and Lung Tumors
2
Adjuvant Chemotherapy Improves Long-Term Survival in Endometrial Cancer
3
Anti-TIGIT Combination Therapy Yields Positive Survival in Gastric Cancers
4
Fruquintinib Combo Prolongs PFS in Advanced/Metastatic RCC
5
